Project

NBD 01 I ISCHEMIA - Academic Lab IRB

Ischemia, a restriction of blood and oxygen to the tissues, most frequently affects the heart and brain. Globally, cardiovascular disease (CVD) is the leading cause of death worldwide, with an estimate of more than 23 million deaths per year by 2030.

Priority European Patent Filed

Project

NBD 02 I PARKISON - Academic Lab: Vall d’Hebron VHIR

Parkinson's disease (PD) is a common neurodegenerative disorder affecting motor functions and the everyday life of more than 10 million people worldwide. Its incidence increases with age, but an estimated 4% of people with PD are diagnosed before age 50.

Hit Generation Stage

Project

NBD 03 I ONCOLOGY-GLIOBLASTOMA - Academic Lab: UB

Glioblastoma is a rare (global incidence of less than 0.01%) but aggressive type of brain tumor for which there is currently no cure and which usually results in death within a few months of diagnosis. This type of tumor mainly occurs in middle-aged adults.

Hit Generation Stage

Project

NBD 04 I ONCOLOGY - Academic Lab: IDIBELL

With more than 3.7 million new cases and 1.9 million deaths each year, cancer represents the second most important cause of death and morbidity in Europe. Although more than 40% of cancer deaths can be prevented, cancer accounts for 20% of deaths in Europe.

Hit to Lead Stage

Project

NBD 05 I DENT DISEASE - Academic Lab: Vall d’Hebron VHIR

Dent disease is a chronic kidney disease that primarily affects males. While symptoms and severity vary, they usually begin in childhood and worsen over time. It is a rare genetic disease that affects about 250 families to date. Current treatments are supportive.

Hit Generation Stage

Project

NBD 06 I SCHIZOPHRENIA - Academic Lab: IMIM

Though not extremely common, it is a serious and chronic mental disorder that drastically impacts everyday life. Worldwide about 1% of the population is diagnosed with schizophrenia, and approximately 1.2% of Americans (3.2 million) have the disorder.

Hit Generation Stage